A director at SSY Group Ltd bought 1,000,000 shares at 4.675HKD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
A director at Bmmi B.S.C sold 200,000 shares at 0.570BHD and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...
A director at Xiangxing International Holding Limited bought 2,920,000 shares at 0.145HKD and the significance rating of the trade was 56/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ove...
Alliance Trust PLC - Net Asset Value ALLIANCE TRUST PLC At the close of business Wednesday 17 April 2024: The Company’s NAV per ordinary share, valued on a bid price basis with Debt at Par, was - excluding income, 1244.5p - including income, 1249.0p The Company’s NAV per ordinary share, valued on a bid price basis with Debt at Fair Value, was - excluding income, 1249.4p - including income, 1253.9p For further information, please contact: - Juniper Partners LimitedTel. +44 (0)131 378 0500 Notes Net Asset Values are calculated i...
EQS-News: Vonovia SE / Key word(s): Sustainability/Rating Vonovia: SBTi confirms climate targets align with 1.5-degree target of Paris Climate Agreement 18.04.2024 / 13:26 CET/CEST The issuer is solely responsible for the content of this announcement. Vonovia: SBTi confirms climate targets align with 1.5-degree target of Paris Climate Agreement Vonovia is one of six companies in Germany's property sector to be validated by the Science Based Targets initiative (SBTi). According to the CDP, Vonovia is recognised as one of the world’s leading companies in climate prot...
EQS-News: ecotel communication ag / Schlagwort(e): Personalie/Personalie ecotel communication ag: Strategischer Wechsel im Vorstand 18.04.2024 / 13:25 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Generationenwechsel vollzogen André Borusiak wird zum 01.07.2024 neuer Vertriebsvorstand Christian van den Boom wird zum 01.09.2024 Finanzvorstand Veränderung des Vorstandes mit ausgewiesenen Branchenexperten unterstützt den beschrittenen Wachstumspfad mit Fokus auf Cloud-Kommunikation und intelligente Breitbandlösungen für Firmenkunde...
EQS-News: ecotel communication ag / Key word(s): Personnel/Personnel ecotel communication ag: Strategic change on the Management Board 18.04.2024 / 13:25 CET/CEST The issuer is solely responsible for the content of this announcement. Generational shift completed André Borusiak takes over as CCO on 1 July 2024 Christian van den Boom takes over as CFO on 1 September 2024 Proven industry experts are joining the Management Board to further the company’s growth, focusing on cloud communication and intelligent broadband solutions for corporate customers (cloud & fibre) Düss...
EQS-News: Evotec SE / Key word(s): Miscellaneous Evotec and Variant Bio enter strategic partnership to discover and develop fibrosis treatments 18.04.2024 / 13:27 CET/CEST The issuer is solely responsible for the content of this announcement. COLLABORATION LEVERAGES VARIANT BIO’S CUTTING-EDGE GENOMIC DISCOVERY PLATFORM AND EVOTEC’S INTEGRATED END-TO-END R&D PLATFORM AND DISEASE AREA EXPERTISE TO ADDRESS UNMET MEDICAL NEED IN FIBROTIC INDICATIONS COMMERCIAL TERMS INCLUDE RESEARCH FUNDING AND MILESTONES AND/OR ROYALTY PAYMENTS TO EVOTEC BASED ON THE OVERALL SUCCESS OF T...
EQS-News: Vonovia SE / Schlagwort(e): Nachhaltigkeit/Rating SBTi bestätigt: Klimaziele von Vonovia im Einklang mit 1,5-Grad-Ziel des Pariser Klimaschutzabkommens 18.04.2024 / 13:26 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. SBTi bestätigt: Klimaziele von Vonovia sind im Einklang mit 1,5-Grad-Ziel des Pariser Klimaschutzabkommens Vonovia ist eines von sechs Unternehmen im Immobiliensektor in Deutschland, das durch die Science Based Targets initiative (SBTi) validiert wurde. Laut CDP gehört Vonovia zu den weltweit führenden...
EQS-News: Evotec SE / Schlagwort(e): Sonstiges Evotec und Variant Bio gehen strategische Partnerschaft zur Entdeckung und Entwicklung von Fibrose-Behandlungen ein 18.04.2024 / 13:27 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. DIE KOLLABORATION NUTZT VARIANT BIOS HOCHMODERNE GENOMIK-FORSCHUNGSPLATTFORM UND EVOTECS INTEGRIERTE END-TO-END F&E-PLATTFORM UND EXPERTISE IM KRANKHEITSBEREICH, UM UNGEDECKTEN MEDIZINISCHEN BEDARF IN FIBROTISCHEN INDIKATIONEN ANZUGEHEN DIE KOMMERZIELLEN BEDINGUNGEN UMFASSEN FORSCHUNGSZAHLUNGEN SOWIE MEIL...
Edison Investment Research Limited Edison issues outlook on Jersey Electricity (JEL): Decarbonisation fuelling growth 18-Apr-2024 / 12:27 GMT/BST The issuer is solely responsible for the content of this announcement. London, UK, 18 April 2024 Edison issues outlook on Jersey Electricity (JEL): Decarbonisation fuelling growth Jersey Electricity (JEL) is intensifying its focus on energy security and electrification across Jersey by creating opportunities to accelerate growth. It successfully navigated the volatile wholesale power price environment in 2020–23, shielding its ...
EQS-News: InnoTec TSS AG / Schlagwort(e): Jahresergebnis InnoTec TSS Gruppe mit deutlichem Umsatz- und Ergebnisrückgang 18.04.2024 / 13:26 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Im Geschäftsjahr 2023 sank der Umsatz im InnoTec TSS-Konzern um 10,9 % auf 114,7 Mio. Euro (Vorjahr 128,8 Mio. Euro). Das Geschäftsfeld Türsysteme erzielte Umsatzerlöse in Höhe von 82,3 Mio. Euro gegenüber 95,8 Mio. Euro im Vorjahr. Das Geschäftsfeld Bauspezialwerte erreichte einen Umsatz in Höhe von 32,4 Mio. Euro gegenüber 32,9 Mio. Euro im Vorjahr....
CoreCard Corporation Schedules First Quarter 2024 Earnings Release and Conference Call NORCROSS, Ga., April 18, 2024 (GLOBE NEWSWIRE) -- CoreCard Corporation (NYSE: CCRD), the leading provider of innovative credit technology solutions and processing services to the financial technology and services market, intends to hold an investor conference call on May 2, 2024, at 11:00 A.M. Eastern Time in conjunction with the company’s earnings release for the quarter ended March 31, 2024. The company plans to issue a press release with the financial results for the period before the market opens on...
JD.com Announces Updates of Its Share Repurchase Program BEIJING, April 18, 2024 (GLOBE NEWSWIRE) -- JD.com, Inc. (“JD.com” or the “Company”) (NASDAQ: JD and HKEX: 9618 (HKD counter) and 89618 (RMB counter)), a leading supply chain-based technology and service provider, today announced that, during the quarter ended March 31, 2024, the Company repurchased a total of 87.5 million Class A ordinary shares (equivalent of 43.8 million ADSs) for a total of US$1.2 billion. All of these shares were repurchased in the open markets from both NASDAQ and the Hong Kong Stock Exchange pursuant to the C...
A director at Optima bank S.A. sold 3,652 shares at 9.900EUR and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...
A director at Motor Oil (Hellas) Corinth Refineries S.A. bought 2,000 shares at 26.090EUR and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ov...
OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report WALTHAM, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, has published its Environmental, Social and Governance (ESG) report for 2024. As a company that provides best-in-class health technology that enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures t...
TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced two additional data presentations from the ULTIMATE I & II Phase 3 trials evaluating BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS), at the 2024 American Academy of Neurology (AAN) annual meeting, being held in Denver, Colorado. Links to the data presented yesterday are included below. ...
Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study -First efficacy signals demonstrated for a gene therapy under development for Oculopharyngeal Muscular Dystrophy (OPMD) which affects ~15,000 patients worldwide- - BB-301 facilitated improvements across multiple measures of swallowing function in the first Phase 1b/2a clinical study subject as compared to pretreatment assessments conducted during the observational natural history portion of the study- -Virtual R&D Day being held today at 9:00 am EDT, details below...
Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update WARMINSTER, Pa., April 18, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for people with chronic hepatitis B virus (cHBV) infection, today announced that it has scheduled its first quarter 2024 financial results and corporate update for Thursday, May 2, 2024. The schedule for the press release and conference call/webcast are as follows: •Q1 2024 Press Release:Thursda...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.